Iino S, Hino K, Kuroki T, Suzuki H, Yamamoto S: Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study. Dig Dis Sci. 1993, 38: 612-618.
Article
CAS
PubMed
Google Scholar
Brillanti S, Garson J, Foli M, Whitby K, Deaville R, Masci C, Miglioli M, Barbara L: A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology. 1994, 107: 812-817.
Article
CAS
PubMed
Google Scholar
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, Howard SV, Mantel N, McPherson K, Peto J, Smith PG: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977, 35: 1-39.
Article
CAS
PubMed
PubMed Central
Google Scholar
Brouwer JT, Nevens F, Kleter B, Elewaut A, Adler M, Brenard R, Chamuleau RA, Michielsen PP, Pirotte J, Hautekeete ML, Weber J, Bourgeois N, Hansen BE, Bronkhorst CM, ten Kate FJ, Heijtink RA, Fevery J, Schalm SW: Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients. J Hepatol. 1998, 28: 951-959. 10.1016/S0168-8278(98)80342-5.
Article
CAS
PubMed
Google Scholar
Schalm SW, Hansen BE, Chemello L, Bellobuono A, Brouwer JT, Weiland O, Cavalletto L, Schvarcz R, Ideo G, Alberti A: Ribavirin enhances the efficacy but not the adverse effects of interferon in chronic hepatitis C. Meta-analysis of individual patient data from European centers. J Hepatol. 1997, 26: 961-966. 10.1016/S0168-8278(97)80103-1.
Article
CAS
PubMed
Google Scholar
Bellobuono A, Mondazzi L, Tempini S, Silini E, Vicari F, Ideo G: Ribavirin and interferon-alpha combination therapy vs interferon-alpha alone in the retreatment of chronic hepatitis C: a randomized clinical trial. J Viral Hepat. 1997, 4: 185-191. 10.1046/j.1365-2893.1997.00142.x.
Article
CAS
PubMed
Google Scholar
Saracco G, Ciancio A, Olivero A, Smedile A, Roffi L, Croce G, Colletta C, Cariti G, Andreoni M, Biglino A, Calleri G, Maggi G, Tappero GF, Orsi PG, Terreni N, Macor A, Di Napoli A, Rinaldi E, Ciccone G, Rizzetto M: A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Hepatology. 2001, 34: 133-138. 10.1053/jhep.2001.25636.
Article
CAS
PubMed
Google Scholar
Pol S, Couzigou P, Bourliere M, Abergel A, Combis JM, Larrey D, Tran A, Moussalli J, Poupon R, Berthelot P, Brechot C: A randomized trial of ribavirin and interferon-alpha vs. interferon-alpha alone in patients with chronic hepatitis C who were non-responders to a previous treatment. Multicenter Study Group under the coordination of the Necker Hospital, Paris, France. J Hepatol. 1999, 31: 1-7. 10.1016/S0168-8278(99)80157-3.
Article
CAS
PubMed
Google Scholar
Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Bellomo G, Belloni G, Grisorio B, Annese M, Bacca D, Francavilla R, Rizzo G, Barbarini G: Interferon-alpha-2B and ribavirin in combination for chronic hepatitis C patients not responding to interferon-alpha alone: an Italian multicenter, randomized, controlled, clinical study. Am J Gastroenterol. 1998, 93: 2445-2451. 10.1016/S0002-9270(98)00583-8.
CAS
PubMed
Google Scholar
Cummings KJ, Lee SM, West ES, Cid-Ruzafa J, Fein SG, Aoki Y, Sulkowski MS, Goodman SN: Interferon and ribavirin vs interferon alone in the re-treatment of chronic hepatitis C previously nonresponsive to interferon: A meta- analysis of randomized trials. Jama. 2001, 285: 193-199. 10.1001/jama.285.2.193.
Article
CAS
PubMed
Google Scholar
Cheng SJ, Bonis PA, Lau J, Pham NQ, Wong JB: Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials. Hepatology. 2001, 33: 231-240. 10.1053/jhep.2001.20675.
Article
CAS
PubMed
Google Scholar
Camma C, Bruno S, Schepis F, Lo Iacono O, Andreone P, Gramenzi AG, Mangia A, Andriulli A, Puoti M, Spadaro A, Freni M, Di Marco V, Cino L, Saracco G, Chiesa A, Crosignani A, Caporaso N, Morisco F, Rumi MG, Craxi A: Retreatment with interferon plus ribavirin of chronic hepatitis C non- responders to interferon monotherapy: a meta-analysis of individual patient data. Gut. 2002, 51: 864-869. 10.1136/gut.51.6.864.
Article
CAS
PubMed
PubMed Central
Google Scholar
Camma C, Giunta M, Chemello L, Alberti A, Toyoda H, Trepo C, Marcellin P, Zahm F, Schalm S, Craxi A: Chronic hepatitis C: interferon retreatment of relapsers. A meta- analysis of individual patient data. European Concerted Action on Viral Hepatitis (EUROHEP). Hepatology. 1999, 30: 801-807. 10.1016/S0168-8278(99)80132-9.
Article
CAS
PubMed
Google Scholar
Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet. 2001, 358: 958-965. 10.1016/S0140-6736(01)06102-5.
Article
CAS
PubMed
Google Scholar
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales F. L., Jr., Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002, 347: 975-982. 10.1056/NEJMoa020047.
Article
CAS
PubMed
Google Scholar